MedTrace Logo

Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease

NCT00695942 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2012-05-17

No results posted yet for this study

Summary

Venous thromboembolic (VTE) disease is the first cause of maternal mortality in the world. Some other pregnancy pathologies called Placental Vascular Pathologies (PVP) are linked to VTE by biological thrombophilia and are the principal cause of perinatal mortality. the identification of predictive factors of risk of occurrence or recurrence of two pathologies could enable us to propose an appropriate monitoring of patients at risk.

Conditions

  • Placental Vascular Pathologies
  • Venous Thromboembolism Diseases

Sponsors & Collaborators

  • ARGOS

    collaborator UNKNOWN

  • Association de la Vallée de l'Ondaine

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Céline CHAULEUR, MD · CHU de Saint-Etienne

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00695942 on ClinicalTrials.gov